Martin Shkreli
American financial investor and businessman
Follow Martin Shkreli on Notably News to receive short updates to your email — rarely!
| August 26 2024 | A federal judge ordered Shkreli to turn over all copies of the Wu-Tang Clan album, including digital versions, and to report the names of individuals he distributed the music to. |
| June 2024 | Shkreli was sued by a cryptocurrency collective that claimed he violated their deal regarding the Wu-Tang Clan album. |
| May 2023 | Vyera Pharmaceuticals, under Shkreli's influence, declared Chapter 11 bankruptcy in Delaware court, citing declining profits and increased competition. |
| 2022 | Following his release from prison, Martin Shkreli announced a planned software platform named Druglike, aimed at supporting the development of new pharmaceutical drugs. |
| September 2022 | Shkreli left the halfway house in September 2022 and subsequently lived with his sister in Queens. |
| August 2022 | The Martin Shkreli Inu coin, a cryptocurrency project associated with Shkreli, lost 90% of its value after an account believed to belong to him sold its Inu coin holdings. |
| May 18 2022 | Martin Shkreli was released from Allenwood prison and transferred to a Bureau of Prisons halfway house after completing all programs that allowed for his prison sentence to be shortened. |
| February 23 2022 | U.S. District Judge Kiyo Matsumoto ordered Shkreli to pay a $1.39 million fine for violating securities laws and banned him from serving as an officer or director of any publicly traded company for life. |
| January 2022 | Judge Denise Cote ordered Martin Shkreli to return $64.6 million in wrongfully obtained profits and banned him from the pharmaceutical industry for life. |
| 2021 | The United States government auctioned off the Wu-Tang Clan album that Shkreli had bought for $2 million in 2015, selling it to PleasrDAO for $4 million. This sale was noted as completing Shkreli's forfeiture order. |
| December 2021 | A settlement was reached in the FTC case against Vyera Pharmaceuticals, requiring the company to provide up to $40 million in relief over 10 years to consumers and to make Daraprim available to potential generic competitors at the cost of production. Kevin Mulleady agreed to a seven-year ban on working for or holding more than an 8% share in most pharmaceutical companies. |
| 2020 | The Federal Trade Commission and seven states filed a civil lawsuit against Shkreli, leading to a seven-day bench trial in December 2021. |
| April 2020 | Martin Shkreli asked the court for compassionate release, wanting to live at the New York City apartment of his then-fiancée and citing the need to develop a remedy for COVID-19. Judge Matsumoto denied the request. |
| January 2020 | The Federal Trade Commission (FTC) filed a case against Vyera Pharmaceuticals, alleging an elaborate anticompetitive scheme to preserve a monopoly for the life-saving drug, Daraprim. |
| 2019 | Shkreli lost his appeal as the U.S. Court of Appeals for the Second Circuit unanimously affirmed his conviction, requiring him to continue serving his seven-year sentence and to forfeit over $7.3 million in assets. |
| September 6 2019 | Martin Shkreli filed a lawsuit in a Brooklyn court, claiming he was fraudulently persuaded by a former investor in his Elea Capital fund to sign a promissory note that left him owing $420,000. |
| March 2019 | Reports emerged indicating that Martin Shkreli was effectively directing his former company, now named Phoenixus AG, from prison using a contraband cellphone. |
| April 2018 | New York's attorney general requested Judge Matsumoto to grant priority on more than $480,000 from Shkreli's forfeited assets, arguing that the state had precedence over federal claims. |
| April 2018 | In April 2018, Martin Shkreli was ordered to pay $388,000 in restitution as part of his criminal conviction. |
| April 2018 | Martin Shkreli agreed to a settlement with the Securities and Exchange Commission, resulting in a ban from the securities industry. |
| April 18 2018 | Martin Shkreli was transferred from Metropolitan Detention Center, Brooklyn, to FCI Fort Dix after his request to serve at Canaan was denied. |
| March 2018 | Following his conviction for fraud, a federal court seized assets belonging to Shkreli worth $7.36 million, including the Wu-Tang Clan album. |
| March 27 2018 | Judge Kiyo Matsumoto agreed to recommend Martin Shkreli serve his prison sentence at the minimum-security federal camp at USP Canaan, which he had previously requested. |
| March 9 2018 | Shkreli was sentenced to seven years in federal prison. During sentencing, Judge Kiyo A. Matsumoto noted Shkreli's apparent remorse but criticized him for minimizing his misconduct. |
| March 5 2018 | Shkreli was ordered to forfeit nearly $7.4 million in assets by a court ruling. The order included his assets and specified that if cash was insufficient, items such as a piece of art by Pablo Picasso would be sold to cover the forfeiture. |
| 2017 | After Martin Shkreli was imprisoned, Turing Pharmaceuticals changed its name to Vyera in 2017 to avoid negative publicity. |
| 2017 | During the trial, Shkreli faced requests from prosecutors for a gag order due to his frequent criticisms of them, which he claimed were in response to media baiting. |
| September 2017 | Shkreli attempted to sell Once Upon a Time in Shaolin on eBay, with bids exceeding US$1 million. |
| September 13 2017 | Shkreli's bail was revoked after he made a Facebook post offering $5,000 for a strand of Hillary Clinton's hair, which the judge viewed as solicitation to assault. He was sent to the Metropolitan Detention Center, Brooklyn while awaiting sentencing. |
| August 4 2017 | Martin Shkreli was found guilty on two counts of securities fraud and one count of conspiracy to commit securities fraud by a trial jury, while being acquitted on five other counts. |
| June 2017 | Reuters reported that Shkreli's net worth was reported at $70 million, with his attorney acknowledging that Shkreli still owned shares of Turing Pharmaceuticals worth between $30 and $50 million. |
| February 2017 | By February 2017, Gödel Systems was seeking to raise $1 million through a debt offering, having already raised $50,000 since starting its debt issuance in mid-January 2017. |
| 2016 | Shkreli retained criminal defense attorney Benjamin Brafman to represent him in the securities fraud case. |
| 2016 | In 2016, Imprimis Pharmaceuticals introduced a lower-cost compounded version of Thiola in response to the price increase instigated by Shkreli. |
| December 2016 | The New York State Department of Taxation and Finance issued a tax warrant against Martin Shkreli for $1.26 million due to unpaid taxes. |
| November 2016 | After Donald Trump was elected, Shkreli shared the intro and one track from the Wu-Tang Clan album the day after the election. |
| October 2016 | Shkreli announced on Twitter that he would release the Wu-Tang Clan album for free download if Donald Trump won the 2016 presidential election. |
| August 2016 | Martin Shkreli founded Gödel Systems, Inc, a professional software company aimed at providing data, workflow, and communications solutions for financial, law, and scientific professionals. |
| February 4 2016 | Martin Shkreli appeared before the Committee on Oversight and Government Reform of the U.S. House of Representatives to answer questions regarding the price increase of Daraprim, invoking his Fifth Amendment right against self-incrimination during the testimony. |
| January 2016 | Fortune estimated Martin Shkreli's net worth to be at least $45 million; however, it later updated this figure due to a significant drop in the value of his E-Trade account. |
| December 2015 | Following his arrest, Martin Shkreli was terminated as CEO of KaloBios Pharmaceuticals. |
| December 29 2015 | KaloBios Pharmaceuticals filed for Chapter 11 bankruptcy after being delisted by NASDAQ and the resignation of two directors. |
| December 17 2015 | Martin Shkreli was arrested by the FBI after a federal indictment was filed, charging him with securities fraud in connection with his time at MSMB Capital Management and Retrophin. |
| November 2015 | An investor group led by Martin Shkreli acquired a majority stake in KaloBios Pharmaceuticals, a biopharmaceutical company based in South San Francisco, California, and he was named CEO of the company. |
| November 24 2015 | Shkreli won an auction for the Wu-Tang Clan album Once Upon a Time in Shaolin for US$2 million. |
| November 23 2015 | Turing announced it would not reduce the list price of Daraprim, opting instead to negotiate volume discounts for hospitals. |
| September 2015 | In an interview, Shkreli defended the price hike for Daraprim by comparing it to the pricing of luxury cars and announced plans to lower the price following public backlash. |
| September 17 2015 | Reports surfaced of a price increase for Daraprim, jumping by a factor of 56 overnight, which drew criticism from various medical associations and presidential candidates. |
| August 2015 | Retrophin filed a lawsuit against Shkreli, alleging breaches of duty and misuse of company funds, as well as harassment of a former employee. |
| August 10 2015 | Turing Pharmaceuticals, under Martin Shkreli's business plan, acquired the medication Daraprim from Impax Laboratories. |
|
We are only showing the most recent entries for this topic. |
|
This contents of the box above is based on material from the Wikipedia article Martin Shkreli, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.